Výsledky vyhledávání - "Szafraniec-Buryło S"

Akademický článek

Patient care efficiency in primary healthcare - pilot study in Medical and Diagnostical Centre.

Autor: Prusaczyk A; Medical and Diagnostical Centre, Siedlce, Poland., Bogdan M; Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland., Żuk P; Medical and Diagnostical Centre, Siedlce, Poland., Guzek M; Medical and Diagnostical Centre, Siedlce, Poland., Szafraniec-Buryło S; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Nitsch-Osuch A; Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland., Czech M; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland.

Publikováno v: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2021 Dec 16; Vol. 49 (294), pp. 405-410.

Zobrazit plný text záznamu

Akademický článek

EP1.16-45 The Use of Propensity Score Matching to Analyze the Effectiveness of Medical Procedures on the Example of Survival of Patients with Lung Tumors

Autor: Nojszewska, E., Sielska, A., Szafraniec-Burylo, S., Śliwczyński, A.

Publikováno v: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S1083-S1083

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Epidemiology of multiple myeloma in Poland in the years 2008-2017.

Autor: Waszczuk-Gajda A; Department of Haematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland., Szafraniec-Buryło S; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Kraj L; Department of Haematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland., Skwierawska K; Department of Haematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland., Aleksandrowicz K; MTZ Clinical Research, Warsaw, Poland., Basak GW; Department of Haematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland., Brzozowska M; Division of Quality Services, Procedures and Medical Standards, Medical University of Lodz, Lodz, Poland., Wierzba W; UHE Satellite Campus in Warsaw, University of Humanities and Economics in Lodz, Warsaw, Poland., Jędrzejczak WW; Department of Haematology, Oncology and Internal Diseases, Warsaw Medical University, Warsaw, Poland., Śliwczyński A; UHE Satellite Campus in Warsaw, University of Humanities and Economics in Lodz, Warsaw, Poland.

Publikováno v: Archives of medical science : AMS [Arch Med Sci] 2020 Feb 06; Vol. 19 (3), pp. 645-650. Date of Electronic Publication: 2020 Feb 06 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland.

Autor: Brzozowska M; Department of Drug Economics, National Health Fund, Central Office, Warsaw, Poland.; Division of Quality Services, Procedures and Medical Standards, Medical University of Łódź, Łódź, Poland., Wierzba W; UHE Satellite Campus in Warsaw, University of Humanities and Economics in Łódź, Warsaw, Poland., Szafraniec-Buryło S; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Czech M; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Połowinczak-Przybyłek J; Department of Chemotherapy, Copernicus Memorial Hospital, Medical University of Łódź, Łódź, Poland., Potemski P; Copernicus Memorial Hospital, Comprehensive Cancer Center and Traumatology, Medical University of Łódź, Łódź, Poland., Śliwczyński A; Division of Quality Services, Procedures and Medical Standards, Medical University of Łódź, Łódź, Poland.; Department of Health Services, National Health Fund, Central Office, Warsaw, Poland.

Publikováno v: Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2019 May 23; Vol. 25, pp. 3846-3853. Date of Electronic Publication: 2019 May 23.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland - real-world data.

Autor: Brzozowska M; Division of Quality Services, Procedures and Medical Standards, Medical University of Lodz, Lodz, Poland., Wierzba W; UHE Satelite Campus in Warsaw, University of Humanities and Economics in Lodz, Poland., Szafraniec-Buryło S; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Czech M; Department of Pharmacoeconomics, Institute of Mother and Child, Warsaw, Poland., Majkut G; Analysis and Strategy Department, Central Office, National Health Fund, Warsaw, Poland., Połowinczak-Przybyłek J; Chemotherapy Department, Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland., Potemski P; Comprehensive Cancer Center and Traumatology, Copernicus Memorial Hospital, Medical University of Lodz, Lodz, Poland., Śliwczyński A; Division of Quality Services, Procedures and Medical Standards, Medical University of Lodz, Lodz, Poland.

Publikováno v: Archives of medical science : AMS [Arch Med Sci] 2019 Jan 22; Vol. 17 (6), pp. 1618-1627. Date of Electronic Publication: 2019 Jan 22 (Print Publication: 2021).

Zobrazit plný text záznamu